Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.
about
Thrombolysis for acute ischaemic strokeMagnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptomsThrombolysis for acute ischaemic strokeRecombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisOutcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or olderUse of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trialsManagement of Postthrombolysis Hemorrhagic and Orolingual Angioedema ComplicationsAbsolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom OnsetEffect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsPredicting a post-thrombolysis intracerebral hemorrhage: a systematic reviewChinese guidelines for endovascular management of ischemic cerebrovascular diseasesDiagnosis and management of acute ischemic stroke: speed is criticalStroke, dementia, and drug deliveryTreating the acute stroke patient as an emergency: current practices and future opportunities.Acute therapy and prevention of stroke in spontaneous carotid dissectionStroke preparedness in children: translating knowledge into behavioral intent: a systematic review and meta-analysis.Review article: Why is there still a debate regarding the safety and efficacy of intravenous thrombolysis in the management of presumed acute ischaemic stroke? A systematic review and meta-analysis.Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.Magnetic resonance-guided focused ultrasound surgery: Part 2: A review of current and future applications.Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeManagement of ischaemic stroke in the acute setting: review of the current status.Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onsetRecanalization therapies in acute ischemic stroke: pharmacological agents, devices, and combinations.Modeling disease progression in acute stroke using clinical assessment scales.Therapeutic advances in interventional neurology.Periprocedural aspects in mechanical recanalization for acute stroke: data from the ENDOSTROKE registry.Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes.The very acute stroke treatment: fibrinolysis and after.Imaging of acute stroke prior to treatment: current practice and evolving techniques.Imaging-based management of acute ischemic stroke patients: current neuroradiological perspectives.Thrombolytic-Related Asymptomatic Hemorrhagic Transformation Does Not Deteriorate Clinical Outcome: Data from TIMS in China.Intravenous thrombolysis is more safe and effective for posterior circulation stroke: Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).Review of the current status of intra-arterial thrombolysis for treating acute cerebral infarction: a retrospective analysis of the data from multiple centers in Korea.Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data.Recommendations and treatment strategies for the management of acute ischemic stroke.Thrombolytic Treatment for Ischaemic Stroke: Could the Crisis of Confidence Have Been Avoided by Better Analysis of Trial Data?Halving effort in acute stroke trials.Advances in ischemic stroke treatment: neuroprotective and combination therapies.Clinical review: Imaging in ischaemic stroke--implications for acute management
P2860
Q24194788-AC5213A1-9FA0-44A3-8D82-CA82E3AFD22CQ24239967-ED7BA66E-6CF5-468A-83EA-5FF52EF5B8E8Q24240067-811C1F8A-7DCA-48EC-882F-B553E47539E4Q24595703-B9E89F00-A200-4A50-8522-2097B7AA2D49Q24646395-FDDEB4AA-C891-47AE-86F0-5ECEA3BB4A0AQ24793478-DF7AB949-1241-4F83-90B6-3025BE823616Q26796470-9772A2D1-070C-46B5-9350-C39F1E02D64FQ26796474-0AB31D0A-13FE-45DF-AB3D-60436122EF13Q26796477-D4143CC7-32CB-4DB6-B1E0-996C68F9F2ADQ26823902-096AAAC7-AE91-4E30-BFB6-0FE14745B2E2Q26830834-3C08CDE3-81ED-4731-BF29-3F25B0157583Q26864892-DD498DDE-461A-4CB8-958A-67EFC8C26AEEQ28085439-5DC2D135-D767-4EBE-B5B0-076DFBD0958CQ28166505-44929047-EE89-4778-A87E-229F58E8747EQ28196628-3B5E9069-85E6-4314-A5AA-5AC34B09AC05Q28199361-EE68C269-B868-4666-8069-55BC73022EDEQ30151101-0FEAC9ED-B462-4045-A8A9-B47555A0682EQ30248290-46D5CF73-A02B-4F42-8919-2C572EE53916Q30277030-CA7E7172-09C7-4940-9C78-1F0AAA836923Q30411823-94AF31D3-4D9D-447F-981E-89CB46B3500EQ30414441-1127D526-B5B2-497A-ADA0-58DA5322C065Q30431467-A7C10CDD-FC7A-4D72-8F40-CEECD1E13D57Q30470195-3C8050D2-692D-4358-9F44-F55ACAC9AF13Q30479878-BE5D4521-DF9A-4B80-8234-374FDEAEA9C7Q30497328-C5244E54-3FCD-4221-9EF2-D4112DDF4344Q30499139-861856AA-CFE4-4F43-AAFA-B07AB707831DQ30652275-E623735D-3647-408A-85B8-9602496C5F21Q30671155-33367E38-30C0-44E0-8311-56AD0A46540EQ30749058-3E655B81-C4DE-4A8E-9D3F-A9F154C50C53Q30831710-F02142D5-558D-4732-A58B-BB12D0D21990Q30904038-775332BF-1758-4CA8-B1B6-4CA45F49AC1CQ31029314-83399787-0D19-4606-99D0-305A05756FFAQ31108563-BBDDA6BF-1561-4F3F-8D2E-6B0E8F333F0AQ31108632-FD216471-3908-46E4-931C-FAB9B4DB6C62Q31145197-7DE89805-1B97-4BD6-9816-76ED78B25DE7Q31153077-3BF5CBD7-D912-45DF-B609-7F178AD25A95Q31156580-37ED1FDE-0C6D-4754-933E-4EF34DBBFBE5Q33249571-660C9C5C-9D4F-4D15-B1D7-38459A3A4C09Q33278117-C7AF13BB-2A1D-4ED4-B20A-C287FCDB8018Q33299284-FB745DCB-81C8-404C-8677-4A84F9768C01
P2860
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Randomised double-blind placeb ...... te Stroke Study Investigators.
@en
Randomised double-blind placeb ...... lase in acute ischaemic stroke
@nl
type
label
Randomised double-blind placeb ...... te Stroke Study Investigators.
@en
Randomised double-blind placeb ...... lase in acute ischaemic stroke
@nl
prefLabel
Randomised double-blind placeb ...... te Stroke Study Investigators.
@en
Randomised double-blind placeb ...... lase in acute ischaemic stroke
@nl
P2093
P50
P1433
P1476
Randomised double-blind placeb ...... te Stroke Study Investigators.
@en
P2093
D Schneider
E Diez-Tejedor
R von Kummer
P304
P356
10.1016/S0140-6736(98)08020-9
P407
P577
1998-10-01T00:00:00Z